Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
暂无分享,去创建一个
[1] E. Schleicher,et al. Direct Cross-talk of Interleukin-6 and Insulin Signal Transduction via Insulin Receptor Substrate-1 in Skeletal Muscle Cells* , 2006, Journal of Biological Chemistry.
[2] D. Neculoiu,et al. Evaluation of viral replication in children with chronic hepatitis B with and without interferon treatment. , 2005, Romanian journal of gastroenterology.
[3] M. T. Nunes,et al. NF-κB, MEF2A, MEF2D and HIF1-a involvement on insulin- and contraction-induced regulation of GLUT4 gene expression in soleus muscle , 2005, Molecular and Cellular Endocrinology.
[4] P. Neufer,et al. Substrate availability and transcriptional regulation of metabolic genes in human skeletal muscle during recovery from exercise. , 2005, Metabolism: clinical and experimental.
[5] R. Mooney,et al. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. , 2005, Endocrinology.
[6] H. El-Gabalawy,et al. Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines , 2005, Current opinion in rheumatology.
[7] F. Lönnqvist,et al. Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1 , 2005, Diabetologia.
[8] A. Sharma,et al. Obesity, hypertension and insulin resistance , 2005, Acta Diabetologica.
[9] Bente Klarlund Pedersen,et al. The anti-inflammatory effect of exercise. , 2005, Journal of applied physiology.
[10] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.
[11] M. Febbraio,et al. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. , 2005, American journal of physiology. Endocrinology and metabolism.
[12] S. Jee,et al. Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways. , 2004, The Journal of investigative dermatology.
[13] U. Smith,et al. Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats , 2004, Diabetologia.
[14] M. Febbraio,et al. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. , 2004, Journal of molecular endocrinology.
[15] C. Bruce,et al. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. , 2004, American journal of physiology. Endocrinology and metabolism.
[16] G. Hjälm,et al. The 5′-AMP-activated Protein Kinase γ3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle* , 2004, Journal of Biological Chemistry.
[17] B. Pedersen,et al. AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. , 2004, Biochemical and biophysical research communications.
[18] M. Febbraio,et al. Interleukin-6 and insulin sensitivity: friend or foe? , 2004, Diabetologia.
[19] M. Febbraio,et al. Skeletal myocytes are a source of interleukin‐6 mRNA expression and protein release during contraction: evidence of fiber type specificity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] L. Kuller,et al. The Chronic Inflammatory Hypothesis for the Morbidity Associated with Morbid Obesity: Implications and Effects of Weight Loss , 2004, Obesity surgery.
[21] G. Cline,et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. , 2004, Diabetes.
[22] P. Muñoz-Cánoves,et al. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. , 2004, Molecular biology of the cell.
[23] M. Ishii,et al. Cytoplasmic c‐Fos induced by the YXXQ‐derived STAT3 signal requires the co‐operative MEK/ERK signal for its nuclear translocation , 2004, Genes to cells : devoted to molecular & cellular mechanisms.
[24] U. Smith,et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. , 2004, Obesity research.
[25] T. Kanda,et al. Interleukin-6 and cardiovascular diseases. , 2004, Japanese heart journal.
[26] L. Goodyear,et al. 5’ Adenosine Monophosphate-Activated Protein Kinase, Metabolism and Exercise , 2004, Sports medicine.
[27] D. Constantin-Teodosiu,et al. The effect of repeated muscle biopsy sampling on ATP and glycogen resynthesis following exercise in man , 2004, European Journal of Applied Physiology and Occupational Physiology.
[28] U. Smith,et al. Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects* , 2003, Journal of Biological Chemistry.
[29] A. Steensberg,et al. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. , 2003, Biochemical and biophysical research communications.
[30] A. Steensberg,et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. , 2003, American journal of physiology. Endocrinology and metabolism.
[31] A. Krook,et al. RNA interference-mediated reduction in GLUT1 inhibits serum-induced glucose transport in primary human skeletal muscle cells. , 2003, Biochemical and biophysical research communications.
[32] B. Saltin,et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. , 2003, The Journal of clinical endocrinology and metabolism.
[33] M. Febbraio,et al. Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise. , 2003, Metabolism: clinical and experimental.
[34] S. Keller. The insulin-regulated aminopeptidase: a companion and regulator of GLUT4. , 2003, Frontiers in bioscience : a journal and virtual library.
[35] T. Zimmers,et al. Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes* , 2003, The Journal of Biological Chemistry.
[36] C. Stewart,et al. Role of insulin‐like growth factor binding protein‐3 (IGFBP‐3) in the differentiation of primary human adult skeletal myoblasts , 2003, Journal of cellular physiology.
[37] N. Jessen,et al. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. , 2003, Journal of applied physiology.
[38] Stefan Rose-John,et al. The human interleukin‐6 (IL‐6) receptor exists as a preformed dimer in the plasma membrane , 2003, FEBS letters.
[39] E. Kraegen,et al. Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. , 2001, Biochemical Society transactions.
[40] M. Febbraio. Signaling pathways for IL-6 within skeletal muscle. , 2003, Exercise immunology review.
[41] M. Febbraio,et al. IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle , 2002 .
[42] R. Mooney,et al. Interleukin-6 induces cellular insulin resistance in hepatocytes. , 2002, Diabetes.
[43] M. Febbraio,et al. Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] J. Zierath,et al. Isoform-specific regulation of 5' AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction. , 2002, Diabetes.
[45] Olle Ljunqvist,et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. , 2002, Diabetes.
[46] E. Ravussin,et al. Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus , 2002, Annals of the New York Academy of Sciences.
[47] C. Marboe,et al. The role of IL6 cytokines in acute cardiac allograft rejection. , 2002, Transplant immunology.
[48] W. Winder. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. , 2001, Journal of applied physiology.
[49] L Wood,et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.
[50] L. Goodyear,et al. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. , 1999, Diabetes.
[51] D. Hardie,et al. AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.
[52] B. Kemp,et al. Dealing with energy demand: the AMP-activated protein kinase. , 1999, Trends in biochemical sciences.
[53] G. Hill. Cardiopulmonary bypass-induced inflammation: is it important? , 1998, Journal of cardiothoracic and vascular anesthesia.
[54] R. Somwar,et al. Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells. , 1998, Clinical therapeutics.
[55] J S Yudkin,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .
[56] H. Tilg,et al. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. , 1997, Immunology today.
[57] Michel Georges,et al. A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle , 1997, Nature Genetics.
[58] Hurel Sj. Insulin action in cultured human skeletal muscle. , 1997 .
[59] G. Kannourakis,et al. Leukemia inhibitory factor and interleukin‐6 are produced by diseased and regenerating skeletal muscle , 1996, Muscle & nerve.
[60] S. Okazaki,et al. Effects of calcitonin gene‐related peptide and interleukin 6 on myoblast differentiation , 1996, Cell proliferation.
[61] S. O’Rahilly,et al. Two Naturally Occurring Mutant Insulin Receptors Phosphorylate Insulin Receptor Substrate-1 (IRS-1) but Fail to Mediate the Biological Effects of Insulin , 1996, The Journal of Biological Chemistry.
[62] H. Goebel,et al. Cytokine Expression Profile in Idiopathic Inflammatory Myopathies , 1996, Journal of neuropathology and experimental neurology.
[63] R. Henry,et al. The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.
[64] A. Billiau,et al. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice , 1995, Infection and immunity.
[65] M. Kluger,et al. Cytokines and the acute phase response to influenza virus in mice. , 1995, The American journal of physiology.
[66] R. Hohlfeld,et al. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. , 1994, Immunology letters.
[67] P. Heinrich,et al. Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. , 1992, Biochemical and biophysical research communications.
[68] C. Dinarello,et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.
[69] K. Kristensson,et al. Interferon-gamma-like immunoreactivity and T-cell marker expression in rat skeletal muscle fibres , 1989, Brain Research.
[70] T. Hirano,et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.
[71] Blom Pc,et al. Exhaustive running: inappropriate as a stimulus of muscle glycogen super-compensation. , 1987 .
[72] N. Vøllestad,et al. Exhaustive running: inappropriate as a stimulus of muscle glycogen super-compensation. , 1987, Medicine and science in sports and exercise.